Clinical trials
Observational Atherosclerosis trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2017 | 5 |
| 2018 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Edinburgh | 4 |
| Cambridge University Hospitals NHS Foundation Trust | 2 |
| University of Cambridge | 2 |
| Bayer | 1 |
| Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 1 |
| East and North Hertfordshire NHS Trust | 1 |
| Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | 1 |
| GlaxoSmithKline | 1 |
| Golden Jubilee National Hospital | 1 |
| Infraredx | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 22 |
| Cardiovascular Diseases | 8 |
| Coronary Artery Disease | 7 |
| Inflammation | 4 |
| Stroke | 4 |
| Dyslipidemias | 3 |
| Hypercholesterolemia | 3 |
| Myocardial Infarction | 3 |
| Acute Coronary Syndrome | 2 |
| Carotid Stenosis | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.